Literature DB >> 14970914

[How frequent are diabetes-related amputations of the lower limbs in Germany? An analysis on the basis of routine data].

G Heller1, C Günster, H Schellschmidt.   

Abstract

BACKGROUND AND
OBJECTIVE: The total number of lower limb amputations in Germany as well as the frequency of lower limb amputations attributable to diabetes is unknown. Currently available estimates are based on regional studies resulting in different totals. The aim of this study was to perform a census of all lower limb amputations in Germany in order to obtain valid estimates of the number of amputations attributable to diabetes mellitus in Germany. PATIENTS AND METHODS: Hospital performance and expenditure statistics were used to obtain a comprehensive count of lower limb amputations. The number of amputations in diabetic patients as well as the number of diabetes-related amputations were assessed by calculating the proportion of diabetes among amputees as well as attributable amputations standardized to the age and gender distribution in Germany in 2001, using routine data from the Local Health Insurance Funds (AOK) as well as previous analyses from Germany.
RESULTS: In 2001, 43,544 lower limb amputations and additional 3,981 revisions of amputations were performed in Germany. Among these almost 29,000 lower limb amputations were estimated to be performed in diabetic patients. More than 26,000 lower limb amputations per year were estimated to have been attributable to pre-existing diabetes mellitus.
CONCLUSIONS: Lower limb amputations as a complication of diabetes mellitus are more frequent in Germany than previously estimated. Intensified prevention and therapy--as intended in disease management programs--are urgently needed to decrease the complications of diabetes and ultimately to reduce diabetes mellitus-related costs.

Entities:  

Mesh:

Year:  2004        PMID: 14970914     DOI: 10.1055/s-2004-820063

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  9 in total

1.  Comment to: Jeffcoate W J, van Houtum W H (2004) Amputation as a marker of the quality of foot care in diabetes. Diabetologia 47:2051-2058.

Authors:  E Chantelau
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

Review 2.  [Postoperative complications in vascular surgery].

Authors:  H Diener; A Larena-Avellaneda; E S Debus
Journal:  Chirurg       Date:  2009-09       Impact factor: 0.955

3.  Amputation Statistics-How to Interpret Them?

Authors:  Gerhard Rümenapf; Stephan Morbach
Journal:  Dtsch Arztebl Int       Date:  2017-02-24       Impact factor: 5.594

4.  [Diabetic foot syndrome from the perspective of angiology and diabetology].

Authors:  H Lawall; C Diehm
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

Review 5.  [Diabetic foot syndrome].

Authors:  H Lawall; H Reike
Journal:  Internist (Berl)       Date:  2009-08       Impact factor: 0.743

6.  Re-amputation occurrence in the diabetic population in South Wales, UK.

Authors:  Rajani Kanade; Robert van Deursen; Jo Burton; Vanessa Davies; Keith Harding; Patricia Price
Journal:  Int Wound J       Date:  2007-10-24       Impact factor: 3.315

Review 7.  Pathophysiology of chronic limb ischemia.

Authors:  F Simon; A Oberhuber; N Floros; P Düppers; H Schelzig; M Duran
Journal:  Gefasschirurgie       Date:  2018-04-10

8.  Decrease in (Major) Amputations in Diabetics: A Secondary Data Analysis by AOK Rheinland/Hamburg.

Authors:  Melanie May; Sebastian Hahn; Claudia Tonn; Gerald Engels; Dirk Hochlenert
Journal:  J Diabetes Res       Date:  2016-01-05       Impact factor: 4.011

9.  Lower-extremity amputations in people with and without diabetes in Germany, 2008-2012 - an analysis of more than 30 million inhabitants.

Authors:  Heiner Claessen; Maria Narres; Burkhard Haastert; Werner Arend; Falk Hoffmann; Stephan Morbach; Gerhard Rümenapf; Tatjana Kvitkina; Heiko Friedel; Christian Günster; Ingrid Schubert; Walter Ullrich; Benjamin Westerhoff; Adrian Wilk; Andrea Icks
Journal:  Clin Epidemiol       Date:  2018-04-20       Impact factor: 4.790

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.